Page de couverture de Avelumab in Cancer

Avelumab in Cancer

Avelumab in Cancer

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma.


Common side effects include fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reactions, rash, decreased appetite and swelling of the limbs (peripheral edema).


Avelumab targets the protein programmed death-ligand 1 (PD-L1). It has received orphan drug designation by the European Medicines Agency (EMA) for the treatment of gastric cancer in January 2017. The US Food and Drug Administration (FDA) approved it in March 2017 for Merkel-cell carcinoma.


Listen to this informative epiosode to know more about the drug.


We hope this helps.


See you soon...


Jai Hind

Ce que les auditeurs disent de Avelumab in Cancer

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.